The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hereditary Angioedema Treatment Market Research Report 2025
Synopsis
The global Hereditary Angioedema Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Treatment.
Report Scope
The Hereditary Angioedema Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Angioedema Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Segment by Type
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hereditary Angioedema Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Treatment.
Report Scope
The Hereditary Angioedema Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Angioedema Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Segment by Type
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hereditary Angioedema Treatment Market Overview
1.1 Product Overview and Scope of Hereditary Angioedema Treatment
1.2 Hereditary Angioedema Treatment Segment by Type
1.2.1 Global Hereditary Angioedema Treatment Market Value Comparison by Type (2024-2030)
1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.2.5 Others (Conventional Drugs, Pipeline Drugs)
1.3 Hereditary Angioedema Treatment Segment by Application
1.3.1 Global Hereditary Angioedema Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others (online pharmacies, mail pharmacies)
1.4 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts
1.4.1 Global Hereditary Angioedema Treatment Revenue 2019-2030
1.4.2 Global Hereditary Angioedema Treatment Sales 2019-2030
1.4.3 Global Hereditary Angioedema Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hereditary Angioedema Treatment Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Hereditary Angioedema Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hereditary Angioedema Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hereditary Angioedema Treatment, Product Type & Application
2.7 Hereditary Angioedema Treatment Market Competitive Situation and Trends
2.7.1 Hereditary Angioedema Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue
2.7.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hereditary Angioedema Treatment Retrospective Market Scenario by Region
3.1 Global Hereditary Angioedema Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hereditary Angioedema Treatment Global Hereditary Angioedema Treatment Sales by Region: 2019-2030
3.2.1 Global Hereditary Angioedema Treatment Sales by Region: 2019-2024
3.2.2 Global Hereditary Angioedema Treatment Sales by Region: 2025-2030
3.3 Global Hereditary Angioedema Treatment Global Hereditary Angioedema Treatment Revenue by Region: 2019-2030
3.3.1 Global Hereditary Angioedema Treatment Revenue by Region: 2019-2024
3.3.2 Global Hereditary Angioedema Treatment Revenue by Region: 2025-2030
3.4 North America Hereditary Angioedema Treatment Market Facts & Figures by Country
3.4.1 North America Hereditary Angioedema Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hereditary Angioedema Treatment Sales by Country (2019-2030)
3.4.3 North America Hereditary Angioedema Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hereditary Angioedema Treatment Market Facts & Figures by Country
3.5.1 Europe Hereditary Angioedema Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hereditary Angioedema Treatment Sales by Country (2019-2030)
3.5.3 Europe Hereditary Angioedema Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Hereditary Angioedema Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hereditary Angioedema Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Hereditary Angioedema Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hereditary Angioedema Treatment Market Facts & Figures by Country
3.7.1 Latin America Hereditary Angioedema Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hereditary Angioedema Treatment Sales by Country (2019-2030)
3.7.3 Latin America Hereditary Angioedema Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Hereditary Angioedema Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hereditary Angioedema Treatment Sales by Type (2019-2030)
4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2019-2024)
4.1.2 Global Hereditary Angioedema Treatment Sales by Type (2025-2030)
4.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2030)
4.2 Global Hereditary Angioedema Treatment Revenue by Type (2019-2030)
4.2.1 Global Hereditary Angioedema Treatment Revenue by Type (2019-2024)
4.2.2 Global Hereditary Angioedema Treatment Revenue by Type (2025-2030)
4.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Hereditary Angioedema Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hereditary Angioedema Treatment Sales by Application (2019-2030)
5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2019-2024)
5.1.2 Global Hereditary Angioedema Treatment Sales by Application (2025-2030)
5.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2030)
5.2 Global Hereditary Angioedema Treatment Revenue by Application (2019-2030)
5.2.1 Global Hereditary Angioedema Treatment Revenue by Application (2019-2024)
5.2.2 Global Hereditary Angioedema Treatment Revenue by Application (2025-2030)
5.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Hereditary Angioedema Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Hereditary Angioedema Treatment Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Pharming Group
6.2.1 Pharming Group Corporation Information
6.2.2 Pharming Group Description and Business Overview
6.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pharming Group Hereditary Angioedema Treatment Product Portfolio
6.2.5 Pharming Group Recent Developments/Updates
6.3 Shire plc (Takeda Pharmaceutical Company Limited)
6.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
6.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
6.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolio
6.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments/Updates
6.4 Ionis Pharmaceuticals
6.4.1 Ionis Pharmaceuticals Corporation Information
6.4.2 Ionis Pharmaceuticals Description and Business Overview
6.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio
6.4.5 Ionis Pharmaceuticals Recent Developments/Updates
6.5 Attune Pharmaceuticals
6.5.1 Attune Pharmaceuticals Corporation Information
6.5.2 Attune Pharmaceuticals Description and Business Overview
6.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio
6.5.5 Attune Pharmaceuticals Recent Developments/Updates
6.6 BioCryst Pharmaceuticals
6.6.1 BioCryst Pharmaceuticals Corporation Information
6.6.2 BioCryst Pharmaceuticals Description and Business Overview
6.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio
6.6.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.7 KalVista Pharmaceuticals
6.6.1 KalVista Pharmaceuticals Corporation Information
6.6.2 KalVista Pharmaceuticals Description and Business Overview
6.6.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolio
6.7.5 KalVista Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hereditary Angioedema Treatment Industry Chain Analysis
7.2 Hereditary Angioedema Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hereditary Angioedema Treatment Production Mode & Process
7.4 Hereditary Angioedema Treatment Sales and Marketing
7.4.1 Hereditary Angioedema Treatment Sales Channels
7.4.2 Hereditary Angioedema Treatment Distributors
7.5 Hereditary Angioedema Treatment Customers
8 Hereditary Angioedema Treatment Market Dynamics
8.1 Hereditary Angioedema Treatment Industry Trends
8.2 Hereditary Angioedema Treatment Market Drivers
8.3 Hereditary Angioedema Treatment Market Challenges
8.4 Hereditary Angioedema Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
